ABEO - Company ID 0000318306
The table below shows ABEONA THERAPEUTICS INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $8.72M | - | $400.00K | - | - | - |
| Cost of revenue | $2.70M | $488.00K | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $9.55M | $4.22M | $5.94M | $9.94M | $8.94M | $9.22M |
ABEONA THERAPEUTICS INC. reported annual revenue of $5.82M for fiscal year 2025. That is up 66.3% from $3.50M in fiscal 2023. Over the 10 fiscal years shown, annual revenue grew from $925.00K (FY 2014) to $5.82M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $19.50M |
| $19.31M |
| $17.15M |
| $9.79M |
| $6.40M |
| $8.65M |
| Operating income | -$23.03M | -$24.02M | -$22.79M | -$19.73M | -$15.35M | -$17.86M |
| Income tax | $2.00K | -$15.20M | $15.51M | - | - | - |
| Net income | -$17.07M | -$5.16M | $108.83M | -$12.03M | -$30.27M | $7.41M |
| EPS (diluted) | -$0.30 | -$0.10 | $1.71 | -$0.24 | -$0.63 | -$0.26 |